{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T09:18:11Z","timestamp":1791105491320,"version":"4.1.0"},"reference-count":242,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"National Research Foundation of South Africa"},{"DOI":"10.13039\/501100001322","name":"Medical Research Council (MRC) of South Africa","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001322","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["thebonejournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bone"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1016\/j.bone.2013.06.016","type":"journal-article","created":{"date-parts":[[2013,6,22]],"date-time":"2013-06-22T19:15:19Z","timestamp":1371928519000},"page":"255-265","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":48,"title":["Determinants of bone marrow adiposity: The modulation of peroxisome proliferator-activated receptor-\u03b32 activity as a central mechanism"],"prefix":"10.1016","volume":"56","author":[{"given":"H.","family":"Sadie-Van Gijsen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.S.","family":"Hough","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.F.","family":"Ferris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bone.2013.06.016_bb0005","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.coph.2004.03.002","article-title":"Controlling the balance between osteoblastogenesis and adipogenesis and the consequent therapeutic implications","volume":"4","author":"Nuttall","year":"2004","journal-title":"Curr Opin Pharmacol"},{"key":"10.1016\/j.bone.2013.06.016_bb0010","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1002\/jcb.20777","article-title":"Playing with bone and fat","volume":"98","author":"Gimble","year":"2006","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.bone.2013.06.016_bb0015","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1023\/A:1011513223894","article-title":"Adipocyte tissue volume in bone marrow is increased with aging and in patients with osteoporosis","volume":"2","author":"Justesen","year":"2001","journal-title":"Biogerontology"},{"key":"10.1016\/j.bone.2013.06.016_bb0020","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1136\/jcp.55.9.693","article-title":"Adipocytic proportion of bone marrow is inversely related to bone formation in osteoporosis","volume":"55","author":"Verma","year":"2002","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.bone.2013.06.016_bb0025","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1007\/s00198-006-0285-9","article-title":"MRI-measured bone marrow adipose tissue is inversely related to DXA-measured bone mineral in Caucasian women","volume":"18","author":"Shen","year":"2007","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.bone.2013.06.016_bb0030","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1210\/jc.2007-2691","article-title":"Reciprocal relation between marrow adiposity and the amount of bone in the axial and appendicular skeleton of young adults","volume":"93","author":"Di Iorgi","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.bone.2013.06.016_bb0035","doi-asserted-by":"crossref","first-page":"2977","DOI":"10.1210\/jc.2009-2336","article-title":"Bone acquisition in healthy young females is reciprocally related to marrow adiposity","volume":"95","author":"Di Iorgi","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.bone.2013.06.016_bb0040","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1210\/jc.2010-1922","article-title":"Bone marrow fat is inversely correlated to cortical bone in young and old subjects","volume":"96","author":"Wren","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.bone.2013.06.016_bb0045","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/oby.2010.106","article-title":"Vertebral bone marrow fat is positively associated with visceral fat and inversely associated with IGF-1 in obese women","volume":"19","author":"Bredella","year":"2011","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.bone.2013.06.016_bb0050","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1210\/jc.2011-2605","article-title":"Relationship between MRI-measured bone marrow adipose tissue and hip and spine bone mineral density in African\u2013American and Caucasian participants: the CARDIA study","volume":"97","author":"Shen","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.bone.2013.06.016_bb0055","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1096\/fj.03-1100fje","article-title":"Transdifferentiation potential of human mesenchymal stem cells derived from bone marrow","volume":"18","author":"Song","year":"2004","journal-title":"FASEB J"},{"key":"10.1016\/j.bone.2013.06.016_bb0060","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1148\/radiology.175.1.2315484","article-title":"Red and yellow marrow in the femur: age-related changes in appearance at MR imaging","volume":"175","author":"Moore","year":"1990","journal-title":"Radiology"},{"key":"10.1016\/j.bone.2013.06.016_bb0065","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1002\/1522-2586(200102)13:2<263::AID-JMRI1038>3.0.CO;2-M","article-title":"Age- and sex-specific differences in the 1H-spectrum of vertebral bone marrow","volume":"13","author":"Kugel","year":"2001","journal-title":"J Magn Reson Imaging"},{"key":"10.1016\/j.bone.2013.06.016_bb0070","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1002\/jmri.21072","article-title":"Age, gender, and skeletal variation in bone marrow composition: a preliminary study at 3.0 Tesla","volume":"26","author":"Liney","year":"2007","journal-title":"J Magn Reson Imaging"},{"key":"10.1016\/j.bone.2013.06.016_bb0075","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/8756-3282(93)90239-7","article-title":"Fat fraction of lumbar bone marrow using in vivo proton nuclear magnetic resonance spectroscopy","volume":"14","author":"De Bisschop","year":"1993","journal-title":"Bone"},{"key":"10.1016\/j.bone.2013.06.016_bb0080","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1002\/jmri.23619","article-title":"Bone marrow fat content in the elderly: a reversal of sex difference seen in younger subjects","volume":"36","author":"Griffith","year":"2012","journal-title":"J Magn Reson Imaging"},{"key":"10.1016\/j.bone.2013.06.016_bb0085","first-page":"34","article-title":"Age-related variations of fat tissue fraction in normal human bone marrow depend both on size and number of adipocytes: a stereological study","volume":"17","author":"Rozman","year":"1989","journal-title":"Exp Hematol"},{"key":"10.1016\/j.bone.2013.06.016_bb0090","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1359\/jbmr.090805","article-title":"Bone marrow changes in adolescent girls with anorexia nervosa","volume":"25","author":"Ecklund","year":"2010","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.bone.2013.06.016_bb0095","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1002\/jbmr.82","article-title":"Caloric restriction leads to high marrow adiposity and low bone mass in growing mice","volume":"25","author":"Devlin","year":"2010","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.bone.2013.06.016_bb0100","first-page":"2791","article-title":"Estimation of body fat and lean tissue distribution by dual energy x-ray absorptiometry and abdominal body fat evaluation by computed tomography in Cushing's disease","volume":"80","author":"Wajchenberg","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.bone.2013.06.016_bb0105","first-page":"291","article-title":"The regulation of adipose tissue distribution in humans","volume":"20","author":"Bj\u00f6rntorp","year":"1996","journal-title":"Int J Obes Relat Metab Disord"},{"key":"10.1016\/j.bone.2013.06.016_bb0110","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1002\/1529-0131(199907)42:7<1405::AID-ANR14>3.0.CO;2-W","article-title":"Fat conversion of femoral marrow in glucocorticoid-treated patients: a cross-sectional and longitudinal study with magnetic resonance imaging","volume":"42","author":"Vande Berg","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.bone.2013.06.016_bb0115","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1002\/jmri.22757","article-title":"Does vertebral bone marrow fat content correlate with abdominal adipose tissue, lumbar spine bone mineral density, and blood biomarkers in women with type 2 diabetes mellitus?","volume":"35","author":"Baum","year":"2012","journal-title":"J Magn Reson Imaging"},{"key":"10.1016\/j.bone.2013.06.016_bb0120","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1210\/jc.2011-3123","article-title":"Body composition and cardiovascular risk markers after remission of Cushing's disease: a prospective study using whole-body MRI","volume":"97","author":"Geer","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.bone.2013.06.016_bb0125","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S8756-3282(96)00258-X","article-title":"The function of adipocytes in the bone marrow stroma: an update","volume":"19","author":"Gimble","year":"1996","journal-title":"Bone"},{"key":"10.1016\/j.bone.2013.06.016_bb0130","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/ncprheum0070","article-title":"Mechanisms of disease: is osteoporosis the obesity of bone?","volume":"2","author":"Rosen","year":"2006","journal-title":"Nat Clin Pract Rheumatol"},{"key":"10.1016\/j.bone.2013.06.016_bb0135","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.bone.2011.06.032","article-title":"Marrow fat metabolism is linked to the systemic energy metabolism","volume":"50","author":"Lecka-Czernik","year":"2012","journal-title":"Bone"},{"key":"10.1016\/j.bone.2013.06.016_bb0140","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1038\/nrendo.2010.155","article-title":"PPARgamma: a circadian transcription factor in adipogenesis and osteogenesis","volume":"6","author":"Kawai","year":"2010","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.bone.2013.06.016_bb0145","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.bone.2011.06.016","article-title":"Bone marrow fat has brown adipose tissue characteristics, which are attenuated with aging and diabetes","volume":"50","author":"Krings","year":"2012","journal-title":"Bone"},{"key":"10.1016\/j.bone.2013.06.016_bb0150","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1016\/S0022-2275(20)37320-X","article-title":"Effects of catecholamines on free fatty acid release from bone marrow adipose tissue","volume":"22","author":"Tran","year":"1981","journal-title":"J Lipid Res"},{"key":"10.1016\/j.bone.2013.06.016_bb0155","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1007\/s11914-010-0016-1","article-title":"PPARs in bone: the role in bone cell differentiation and regulation of energy metabolism","volume":"8","author":"Lecka-Czernik","year":"2010","journal-title":"Curr Osteoporos Rep"},{"key":"10.1016\/j.bone.2013.06.016_bb0160","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1007\/s00018-012-1211-2","article-title":"The interrelationship between bone and fat: from cellular see-saw to endocrine reciprocity","volume":"70","author":"Sadie-Van Gijsen","year":"2013","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.bone.2013.06.016_bb0165","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1111\/j.1582-4934.2009.00751.x","article-title":"Inhibition of fatty acid biosynthesis prevents adipocyte lipotoxicity on human osteoblasts in vitro","volume":"14","author":"Elbaz","year":"2010","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.bone.2013.06.016_bb0170","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/j.bbrc.2009.03.111","article-title":"Bone marrow adipocytes support dexamethasone-induced osteoclast differentiation","volume":"382","author":"Hozumi","year":"2009","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.bone.2013.06.016_bb0175","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1080\/14653240802582083","article-title":"Adipocyte differentiation defect in mesenchymal stromal cell of patients with malignant infantile osteopetrosis","volume":"11","author":"Uckan","year":"2009","journal-title":"Cytotherapy"},{"key":"10.1016\/j.bone.2013.06.016_bb0180","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/nature08099","article-title":"Bone-marrow adipocytes as negative regulators of the haematopoietic microenvironment","volume":"460","author":"Naveiras","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.bone.2013.06.016_bb0185","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1182\/blood.V81.5.1184.1184","article-title":"Changes in hematopoiesis-supporting ability of C3H10T1\/2 mouse embryo fibroblasts during differentiation","volume":"81","author":"Nishikawa","year":"1993","journal-title":"Blood"},{"key":"10.1016\/j.bone.2013.06.016_bb0190","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1634\/stemcells.2008-0068","article-title":"Human bone marrow adipocytes block granulopoiesis through neurolipin-1-induced granulocyte colony-stimulating factor inhibition","volume":"26","author":"Belaid-Choucair","year":"2008","journal-title":"Stem Cells"},{"key":"10.1016\/j.bone.2013.06.016_bb0195","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.2337\/db07-0007","article-title":"The adipokine lipocalin 2 is regulated by obesity and promotes insulin resistance","volume":"56","author":"Yan","year":"2007","journal-title":"Diabetes"},{"key":"10.1016\/j.bone.2013.06.016_bb0200","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1002\/jcp.21334","article-title":"Lipocalin 2-mediated growth suppression is evident in human erythroid and monocyte\/macrophage lineage cells","volume":"215","author":"Miharada","year":"2008","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.bone.2013.06.016_bb0205","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1172\/JCI117899","article-title":"The expression of tumor necrosis factor in human adipose tissue. Regulation by obesity, weight loss, and relationship to lipoprotein lipase","volume":"95","author":"Kern","year":"1995","journal-title":"J Clin Invest"},{"key":"10.1016\/j.bone.2013.06.016_bb0210","doi-asserted-by":"crossref","first-page":"2930","DOI":"10.1182\/blood.V86.8.2930.2930","article-title":"Tumor necrosis factor (TNF) is a physiologic regulator of hematopoietic progenitor cells: increase of early hematopoeitic progenitors in TNF receptor p55-deficient mice in vivo and potent inhibition of progenitor cell proliferation by TNF alpha in vitro","volume":"86","author":"Zhang","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.bone.2013.06.016_bb0215","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1182\/blood.V96.5.1723","article-title":"Adiponectin, a new member of the family of soluble defense collagens, negatively regulates the growth of myelomonocytic progenitors and the functions of macrophages","volume":"96","author":"Yokota","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.bone.2013.06.016_bb0220","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1126\/science.284.5411.143","article-title":"Multilineage potential of adult human mesenchymal stem cells","volume":"284","author":"Pittenger","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.bone.2013.06.016_bb0225","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1586\/erd.09.48","article-title":"Adult stem cells in tissue engineering","volume":"6","author":"Hodgkinson","year":"2009","journal-title":"Expert Rev Med Devices"},{"key":"10.1016\/j.bone.2013.06.016_bb0230","doi-asserted-by":"crossref","first-page":"27489","DOI":"10.1155\/PPAR\/2006\/27489","article-title":"Resolving the two \u201cbony\u201d faces of PPAR-gamma","volume":"2006","author":"Lecka-Czernik","year":"2006","journal-title":"PPAR Res"},{"key":"10.1016\/j.bone.2013.06.016_bb0235","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/1471-213X-8-71","article-title":"The PPARgamma-selective ligand BRL-49653 differentially regulates the fate choices of rat calvaria versus rat bone marrow stromal cell populations","volume":"8","author":"Hasegawa","year":"2008","journal-title":"BMC Dev Biol"},{"key":"10.1016\/j.bone.2013.06.016_bb0240","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1210\/en.2009-0987","article-title":"Altered metabolism and lipodystrophy in the early B-cell factor 1-deficient mouse","volume":"151","author":"Fretz","year":"2010","journal-title":"Endocrinology"},{"key":"10.1016\/j.bone.2013.06.016_bb0245","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1016\/j.bone.2009.12.020","article-title":"Decreased osteoclastogenesis and high bone mass in mice with impaired insulin clearance due to liver-specific inactivation to CEACAM1","volume":"46","author":"Huang","year":"2010","journal-title":"Bone"},{"key":"10.1016\/j.bone.2013.06.016_bb0250","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1002\/jbmr.1782","article-title":"Pharmacological inhibition of PPAR\u03b3 increases osteoblastogenesis and bone mass in male C57BL\/6 mice","volume":"28","author":"Duque","year":"2013","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.bone.2013.06.016_bb0255","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1146\/annurev.biochem.77.061307.091829","article-title":"Fat and beyond: the diverse biology of PPARgamma","volume":"77","author":"Tontonoz","year":"2008","journal-title":"Annu Rev Biochem"},{"key":"10.1016\/j.bone.2013.06.016_bb0260","doi-asserted-by":"crossref","first-page":"7921","DOI":"10.1073\/pnas.92.17.7921","article-title":"Structural organization of mouse peroxisome proliferator-activated receptor gamma (mPPAR gamma) gene: alternative promoter use and different splicing yield two mPPAR gamma isoforms","volume":"92","author":"Zhu","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.bone.2013.06.016_bb0265","doi-asserted-by":"crossref","first-page":"18779","DOI":"10.1074\/jbc.272.30.18779","article-title":"The organization, promoter analysis, and expression of the human PPARgamma gene","volume":"272","author":"Fajas","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bone.2013.06.016_bb0270","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1101\/gad.8.10.1224","article-title":"mPPAR gamma 2: tissue-specific regulator of an adipocyte enhancer","volume":"8","author":"Tontonoz","year":"1994","journal-title":"Genes Dev"},{"key":"10.1016\/j.bone.2013.06.016_bb0275","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1002\/jcb.21994","article-title":"PPARgamma2 nuclear receptor controls multiple regulatory pathways of osteoblast differentiation from marrow mesenchymal stem cells","volume":"106","author":"Shockley","year":"2009","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.bone.2013.06.016_bb0280","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1172\/JCI200419900","article-title":"PPARgamma insufficiency enhances osteogenesis through osteoblast formation from bone marrow progenitors","volume":"113","author":"Akune","year":"2004","journal-title":"J Clin Invest"},{"key":"10.1016\/j.bone.2013.06.016_bb0285","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/0092-8674(94)90006-X","article-title":"Stimulation of adipogenesis in fibroblasts by PPAR gamma 2, a lipid-activated transcription factor","volume":"79","author":"Tontonoz","year":"1994","journal-title":"Cell"},{"key":"10.1016\/j.bone.2013.06.016_bb0290","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1159\/000313417","article-title":"Regulation of multilineage gene expression and apoptosis during in vitro expansion of human bone marrow stromal cells with different cell culture media","volume":"192","author":"Zhu","year":"2010","journal-title":"Cells Tissues Organs"},{"key":"10.1016\/j.bone.2013.06.016_bb0295","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.biocel.2011.11.013","article-title":"PPAR\u03b3 suppression inhibits adipogenesis but does not promote osteogenesis of human mesenchymal stem cells","volume":"44","author":"Yu","year":"2012","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1016\/j.bone.2013.06.016_bb0300","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.mce.2010.06.009","article-title":"Depot-specific differences in the insulin response of adipose-derived stromal cells","volume":"328","author":"Sadie-Van Gijsen","year":"2010","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.bone.2013.06.016_bb0305","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0303-7207(00)00211-2","article-title":"A PPARgamma mutant serves as a dominant negative inhibitor of PPAR signaling and is localized in the nucleus","volume":"162","author":"Berger","year":"2000","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.bone.2013.06.016_bb0310","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1128\/MCB.00601-06","article-title":"Interaction with MEK causes nuclear export and downregulation of peroxisome proliferator-activated receptor gamma","volume":"27","author":"Burgermeister","year":"2007","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.bone.2013.06.016_bb0315","doi-asserted-by":"crossref","first-page":"5628","DOI":"10.1093\/nar\/22.25.5628","article-title":"Adipocyte-specific transcription factor ARF6 is a heterodimeric complex of two nuclear hormone receptors, PPAR gamma and RXR alpha","volume":"22","author":"Tontonoz","year":"1994","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.bone.2013.06.016_bb0320","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.abb.2008.03.006","article-title":"Wnt signaling: a win for bone","volume":"473","author":"Piters","year":"2008","journal-title":"Arch Biochem Biophys"},{"key":"10.1016\/j.bone.2013.06.016_bb0325","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.gene.2004.06.044","article-title":"Wnt signaling in osteoblasts and bone diseases","volume":"341","author":"Westendorf","year":"2004","journal-title":"Gene"},{"key":"10.1016\/j.bone.2013.06.016_bb0330","doi-asserted-by":"crossref","first-page":"3324","DOI":"10.1073\/pnas.0408742102","article-title":"Regulation of osteoblastogenesis and bone mass by Wnt10b","volume":"102","author":"Bennett","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.bone.2013.06.016_bb0335","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.bone.2005.01.007","article-title":"Gene array analysis of Wnt-regulated genes in C3H10T1\/2 cells","volume":"36","author":"Jackson","year":"2005","journal-title":"Bone"},{"key":"10.1016\/j.bone.2013.06.016_bb0340","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1042\/bj20030426","article-title":"Peroxisome-proliferator-activated receptor gamma suppresses Wnt\/beta-catenin signalling during adipogenesis","volume":"376","author":"Moldes","year":"2003","journal-title":"Biochem J"},{"key":"10.1016\/j.bone.2013.06.016_bb0345","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/j.bbadis.2012.03.014","article-title":"Controlling a master switch of adipocyte development and insulin sensitivity: covalent modifications of PPAR\u03b3","volume":"1822","author":"Floyd","year":"2012","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.bone.2013.06.016_bb0350","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1038\/ncb1647","article-title":"A histone lysine methyltransferase activated by non-canonical Wnt signalling suppresses PPAR-gamma transactivation","volume":"9","author":"Takada","year":"2007","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.bone.2013.06.016_bb0355","doi-asserted-by":"crossref","first-page":"176","DOI":"10.4161\/cc.5.2.2362","article-title":"TAZ: a beta-catenin-like molecule that regulates mesenchymal stem cell differentiation","volume":"5","author":"Hong","year":"2006","journal-title":"Cell Cycle"},{"key":"10.1016\/j.bone.2013.06.016_bb0360","doi-asserted-by":"crossref","first-page":"34015","DOI":"10.1074\/jbc.M403621200","article-title":"Reciprocal roles of MSX2 in regulation of osteoblast and adipocyte differentiation","volume":"279","author":"Ichida","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bone.2013.06.016_bb0365","doi-asserted-by":"crossref","first-page":"45969","DOI":"10.1074\/jbc.M306972200","article-title":"MSX2 promotes osteogenesis and suppresses adipogenic differentiation of multipotent mesenchymal progenitors","volume":"278","author":"Cheng","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bone.2013.06.016_bb0370","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1002\/(SICI)1097-4644(19990901)74:3<357::AID-JCB5>3.0.CO;2-7","article-title":"Inhibition of Osf2\/Cbfa1 expression and terminal osteoblast differentiation by PPARgamma2","volume":"74","author":"Lecka-Czernik","year":"1999","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.bone.2013.06.016_bb0375","first-page":"115","article-title":"Birth and death of bone cells: basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis","volume":"21","author":"Manolagas","year":"2000","journal-title":"Endocr Rev"},{"key":"10.1016\/j.bone.2013.06.016_bb0380","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1097\/BOR.0b013e3283025e9c","article-title":"Bone and fat connection in aging bone","volume":"20","author":"Duque","year":"2008","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.bone.2013.06.016_bb0385","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1148\/radiol.2363041425","article-title":"Vertebral bone mineral density, marrow perfusion, and fat content in healthy men and men with osteoporosis: dynamic contrast-enhanced MR imaging and MR spectroscopy","volume":"236","author":"Griffith","year":"2005","journal-title":"Radiology"},{"key":"10.1016\/j.bone.2013.06.016_bb0390","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1007\/s00198-008-0574-6","article-title":"Effects of estrogen therapy on bone marrow adipocytes in post-menopausal osteoporotic women","volume":"19","author":"Syed","year":"2008","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.bone.2013.06.016_bb0395","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1359\/jbmr.1997.12.11.1772","article-title":"Increased adipogenesis and myelopoiesis in the bone marrow of SAMP6, a murine model of defective osteoblastogenesis and low turnover osteopenia","volume":"12","author":"Kajkenova","year":"1997","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.bone.2013.06.016_bb0400","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1359\/jbmr.1999.14.7.1115","article-title":"Age-related osteogenic potential of mesenchymal stromal stem cells from human vertebral bone marrow","volume":"14","author":"D'Ippolito","year":"1999","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.bone.2013.06.016_bb0405","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1002\/jcb.1174","article-title":"Age-related decline in the osteogenic potential of human bone marrow cells cultured in three-dimensional collagen sponges","volume":"82","author":"Mueller","year":"2001","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.bone.2013.06.016_bb0410","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1111\/j.1474-9728.2004.00127.x","article-title":"Aging activates adipogenic and suppresses osteogenic programs in mesenchymal marrow stroma\/stem cells: the role of PPAR-\u03b32 transcription factor and TGF-\u00df\/BMP signaling pathway","volume":"3","author":"Moerman","year":"2004","journal-title":"Aging Cell"},{"key":"10.1016\/j.bone.2013.06.016_bb0415","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1007\/s00223-001-2059-x","article-title":"Maintenance of osteoblastic and adipocytic differentiation potential with age and osteoporosis in human marrow stromal cell cultures","volume":"71","author":"Justesen","year":"2002","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.bone.2013.06.016_bb0420","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/35041687","article-title":"Oxidants, oxidative stress and the biology of aging","volume":"408","author":"Finkel","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.bone.2013.06.016_bb0425","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/S0891-5849(01)00610-4","article-title":"Oxidative stress modulates osteoblastic differentiation of vascular and bone cells","volume":"31","author":"Mody","year":"2001","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.bone.2013.06.016_bb0430","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1359\/jbmr.1999.14.12.2067","article-title":"Atherogenic diet and minimally oxidized low density lipoprotein inhibit osteogenic and promote adipogenic differentiation of marrow stromal cells","volume":"14","author":"Parhami","year":"1999","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.bone.2013.06.016_bb0435","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1038\/22572","article-title":"Interleukin-4-dependent production of PPAR-gamma ligands in macrophages by 12\/15-lipoxygenase","volume":"400","author":"Huang","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.bone.2013.06.016_bb0440","doi-asserted-by":"crossref","first-page":"27438","DOI":"10.1074\/jbc.M109.023572","article-title":"Increased lipid oxidation causes oxidative stress, increased peroxisome proliferator-activated receptor-\u03b3 expression, and diminished pro-osteogenic Wnt signalling in the skeleton","volume":"284","author":"Almeida","year":"2009","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bone.2013.06.016_bb0445","doi-asserted-by":"crossref","first-page":"3455","DOI":"10.1172\/JCI42528","article-title":"Maf promotes osteoblast differentiation in mice by mediating the age-related switch in mesenchymal cell differentiation","volume":"120","author":"Nishikawa","year":"2010","journal-title":"J Clin Invest"},{"key":"10.1016\/j.bone.2013.06.016_bb0450","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.bbrc.2003.08.144","article-title":"Regulation and differential expression of the c-maf gene in differentiating cultured cells","volume":"310","author":"Serria","year":"2003","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.bone.2013.06.016_bb0455","doi-asserted-by":"crossref","first-page":"27285","DOI":"10.1074\/jbc.M702810200","article-title":"Skeletal involution by age-associated oxidative stress and its acceleration by loss of sex steroids","volume":"282","author":"Almeida","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bone.2013.06.016_bb0460","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1002\/jcb.20497","article-title":"Osteogenic oxysterols inhibit the adverse effects of oxidative stress on osteogenic differentiation of marrow stromal cells","volume":"95","author":"Shouhed","year":"2005","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.bone.2013.06.016_bb0465","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1359\/jbmr.070710","article-title":"20(S)-hydroxycholesterol inhibits PPARgamma expression and adipogenic differentiation of bone marrow stromal cells through a hedgehog-dependent mechanism","volume":"22","author":"Kim","year":"2007","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.bone.2013.06.016_bb0470","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1002\/jcb.22846","article-title":"Hedgehod signaling and osteogenic differentiation in multipotent bone marrow stromal cells are inhibited by oxidative stress","volume":"111","author":"Kim","year":"2010","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.bone.2013.06.016_bb0475","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.cbi.2008.08.014","article-title":"Hypolipidimic and antioxidant activities of oleuropein and its hydrolysis derivative-rich extracts from Chemlali olive leaves","volume":"176","author":"Jemai","year":"2008","journal-title":"Chem Biol Interact"},{"key":"10.1016\/j.bone.2013.06.016_bb0480","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.nutres.2008.03.014","article-title":"Dietary virgin olive oil protects against lipid peroxidation and improves antioxidant status in the liver of rats chronically exposed to ethanol","volume":"28","author":"Kasdallah-Grissa","year":"2008","journal-title":"Nutr Res"},{"key":"10.1016\/j.bone.2013.06.016_bb0485","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1007\/s00198-010-1270-x","article-title":"Oleuropein enhances osteoblastogenesis and inhibits adipogenesis: the effect of differentiation in stem cells derived from bone marrow","volume":"22","author":"Santiago-Mora","year":"2011","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.bone.2013.06.016_bb0490","first-page":"163","article-title":"Consequences of the diabetic status on the oxidant\/antioxidant balance","volume":"26","author":"Bonnefont-Rousselot","year":"2000","journal-title":"Diabetes Metab"},{"key":"10.1016\/j.bone.2013.06.016_bb0495","doi-asserted-by":"crossref","first-page":"3622","DOI":"10.1210\/en.2004-1677","article-title":"Increased bone adiposity and peroxisomal proliferator-activated receptor-gamma2 expression in type I diabetic mice","volume":"146","author":"Botolin","year":"2005","journal-title":"Endocrinology"},{"key":"10.1016\/j.bone.2013.06.016_bb0500","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1002\/jcp.20804","article-title":"Inhibition of PPARgamma prevents type I diabetic bone marrow adiposity but not bone loss","volume":"209","author":"Botolin","year":"2006","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.bone.2013.06.016_bb0505","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1002\/jcb.23163","article-title":"Caspase-2 deficiency protects mice from diabetes-induced marrow adiposity","volume":"112","author":"Coe","year":"2011","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.bone.2013.06.016_bb0510","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jdiacomp.2011.11.001","article-title":"Human bone marrow adiposity is linked with serum lipids not T1-diabetes","volume":"26","author":"Slade","year":"2012","journal-title":"J Diabet Complicat"},{"key":"10.1016\/j.bone.2013.06.016_bb0515","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1210\/en.2003-1156","article-title":"Modeled microgravity inhibits osteogenic differentiation of human mesenchymal stem cells and increases adipogenesis","volume":"145","author":"Zayzafoon","year":"2004","journal-title":"Endocrinology"},{"key":"10.1016\/j.bone.2013.06.016_bb0520","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1359\/jbmr.2002.17.4.668","article-title":"Transforming growth factor beta2 inhibits adipocyte differentiation induced by skeletal unloading in rat bone marrow stroma","volume":"17","author":"Ahdjoudj","year":"2002","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.bone.2013.06.016_bb0525","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/0273-1177(81)90254-4","article-title":"Skeletal alterations in rats during space flight","volume":"1","author":"Wronski","year":"1981","journal-title":"Adv Space Res"},{"key":"10.1016\/j.bone.2013.06.016_bb0530","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1152\/japplphysiol.91530.2008","article-title":"Bone marrow fat accumulation after 60days of bed rest persisted 1year after activities were resumed along with hemopoietic stimulation: the Women International Space Simulation for Exploration study","volume":"107","author":"Trudel","year":"2009","journal-title":"J Appl Physiol"},{"key":"10.1016\/j.bone.2013.06.016_bb0535","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1007\/BF02405340","article-title":"Marrow changes in paraplegic patients","volume":"36","author":"Minaire","year":"1984","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.bone.2013.06.016_bb0540","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1359\/jbmr.080817","article-title":"Mechanical stimulation of mesenchymal stem cell proliferation and differentiation promotes osteogenesis while preventing dietary-induced obesity","volume":"24","author":"Luu","year":"2009","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.bone.2013.06.016_bb0545","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1007\/s00421-010-1383-0","article-title":"Upregulation of osteogenic factors induced by high-impact jumping suppresses adipogenesis in marrow but not adipogenic transcription factors in rat tibiae","volume":"109","author":"Yuki","year":"2010","journal-title":"Eur J Appl Physiol"},{"key":"10.1016\/j.bone.2013.06.016_bb0550","doi-asserted-by":"crossref","first-page":"2553","DOI":"10.1210\/en.2006-1704","article-title":"Mechanical loading down-regulates peroxisome proliferator-activated receptor gamma in bone marrow stromal cells and favors osteoblastogenesis at the expense of adipogenesis","volume":"148","author":"David","year":"2007","journal-title":"Endocrinology"},{"key":"10.1016\/j.bone.2013.06.016_bb0555","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1007\/s00421-010-1820-0","article-title":"Treadmill training prevents bone loss by inhibition of PPAR\u03b3 expression but not promoting of Runx2 expression in ovariectomized rats","volume":"111","author":"Chen","year":"2011","journal-title":"Eur J Appl Physiol"},{"key":"10.1016\/j.bone.2013.06.016_bb0560","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1152\/jappl.2000.89.3.1046","article-title":"Alterations in skeletal perfusion with simulated microgravity: a possible mechanism for bone remodeling","volume":"89","author":"Colleran","year":"2000","journal-title":"J Appl Physiol"},{"key":"10.1016\/j.bone.2013.06.016_bb0565","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.bbrc.2006.05.169","article-title":"Proliferation and differentiation of bone marrow stromal cells under hypoxic conditions","volume":"347","author":"Ren","year":"2006","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.bone.2013.06.016_bb0570","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/jcp.20054","article-title":"Hypoxia suppresses runx2 independent of modeled microgravity","volume":"200","author":"Ontiveros","year":"2004","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.bone.2013.06.016_bb0575","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1093\/jn\/135.3.437","article-title":"The nutritional status of astronauts is altered after long-term space flight aboard the International Space Station","volume":"135","author":"Smith","year":"2005","journal-title":"J Nutr"},{"key":"10.1016\/j.bone.2013.06.016_bb0580","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1182\/blood.V60.6.1337.1337","article-title":"Adipocyte development and the loss of erythropoietic capacity in the bone marrow of mice after sustained hypertransfusion","volume":"60","author":"Brookoff","year":"1982","journal-title":"Blood"},{"key":"10.1016\/j.bone.2013.06.016_bb0585","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1182\/blood.V64.5.1036.1036","article-title":"Busulfan-induced chronic bone marrow failure: changes in cortical bone, marrow stromal cells, and adherent cell colonies","volume":"64","author":"McManus","year":"1984","journal-title":"Blood"},{"key":"10.1016\/j.bone.2013.06.016_bb0590","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/8756-3282(87)90015-9","article-title":"Changes in trabecular bone, hematopoiesis and bone marrow vessels in aplastic anemia, primary osteoporosis, and old age: a comparative histomorphometric study","volume":"8","author":"Burkhardt","year":"1987","journal-title":"Bone"},{"key":"10.1016\/j.bone.2013.06.016_bb0595","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1080\/10790268.1997.11719485","article-title":"Anemia and serum protein deficiencies in patients with traumatic spinal cord injury","volume":"20","author":"Lipetz","year":"1997","journal-title":"J Spinal Cord Med"},{"key":"10.1016\/j.bone.2013.06.016_bb0600","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/0306-9877(88)90032-1","article-title":"Do bone marrow fat cells or their precursors have a pathogenic role in idiopathic aplastic anemia?","volume":"25","author":"Islam","year":"1988","journal-title":"Med Hypotheses"},{"key":"10.1016\/j.bone.2013.06.016_bb0605","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/j.mehy.2007.01.077","article-title":"Anemia of immobility: caused by adipocyte accumulation in bone marrow","volume":"69","author":"Payne","year":"2007","journal-title":"Med Hypotheses"},{"key":"10.1016\/j.bone.2013.06.016_bb0610","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1016\/j.exphem.2009.09.005","article-title":"Downregulation of GATA-2 and overexpression of adipogenic gene-PPAR\u03b3 in mesenchymal stem cells from patients with aplastic anemia","volume":"37","author":"Xu","year":"2009","journal-title":"Exp Hematol"},{"key":"10.1016\/j.bone.2013.06.016_bb0615","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1358\/dnp.2003.16.9.829340","article-title":"GATA transcription factors and fat cell formation","volume":"16","author":"Tong","year":"2003","journal-title":"Drug News Perspect"},{"key":"10.1016\/j.bone.2013.06.016_bb0620","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1309\/2Y7X-YDXK-006B-XLT2","article-title":"Bone marrow changes in anorexia nervosa are correlated with the amount of weight loss and not with other clinical findings","volume":"118","author":"Abella","year":"2002","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.bone.2013.06.016_bb0625","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1210\/jc.2008-2532","article-title":"Increased bone marrow fat in anorexia nervosa","volume":"94","author":"Bredella","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.bone.2013.06.016_bb0630","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1359\/jbmr.090805","article-title":"Bone marrow changes in adolescent girls with anorexia nervosa","volume":"25","author":"Ecklund","year":"2010","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.bone.2013.06.016_bb0635","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1002\/jbmr.82","article-title":"Caloric restriction leads to high marrow adiposity and low bone mass in growing mice","volume":"25","author":"Devlin","year":"2010","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.bone.2013.06.016_bb0640","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/ncpendmet0872","article-title":"Endocrine abnormalities in anorexia nervosa","volume":"4","author":"Lawson","year":"2008","journal-title":"Nat Clin Pract"},{"key":"10.1016\/j.bone.2013.06.016_bb0645","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1159\/000262540","article-title":"Neuroendocrine consequences of anorexia nervosa in adolescents","volume":"17","author":"Misra","year":"2010","journal-title":"Endocr Dev"},{"key":"10.1016\/j.bone.2013.06.016_bb0650","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1210\/jc.2009-1152","article-title":"Preadipocyte factor-1 is associated with marrow adiposity and bone mineral density in women with anorexia nervosa","volume":"95","author":"Fazeli","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.bone.2013.06.016_bb0655","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s00441-006-0312-3","article-title":"Injections of leptin into rat ventromeidal hypothalamus increase adipocyte apoptosis in peripheral fat and in bone marrow","volume":"327","author":"Hamrick","year":"2007","journal-title":"Cell Tissue Res"},{"key":"10.1016\/j.bone.2013.06.016_bb0660","doi-asserted-by":"crossref","first-page":"4065","DOI":"10.1210\/en.2002-220428","article-title":"Bone marrow adipocytes: a neglected target tissue for growth hormone","volume":"143","author":"Gevers","year":"2002","journal-title":"Endocrinology"},{"key":"10.1016\/j.bone.2013.06.016_bb0665","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/j.bone.2004.07.008","article-title":"Congenic mice with low serum IGF-I have increased body fat, reduced bone mineral density, and an altered osteoblast differentiation program","volume":"35","author":"Rosen","year":"2004","journal-title":"Bone"},{"key":"10.1016\/j.bone.2013.06.016_bb0670","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1002\/ajhb.21202","article-title":"Why does starvation make bones fat?","volume":"23","author":"Devlin","year":"2011","journal-title":"Am J Hum Biol"},{"key":"10.1016\/j.bone.2013.06.016_bb0675","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1007\/s00394-011-0174-7","article-title":"A role for suppressed bone formation favouring catch-up fat in the pathophysiology of catch-up growth after food restriction","volume":"50","author":"Guo","year":"2011","journal-title":"Eur J Nutr"},{"key":"10.1016\/j.bone.2013.06.016_bb0680","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.devcel.2010.07.010","article-title":"Osteoblast precursors, but not mature osteoblasts, move into developing and fractured bones along with invading blood vessels","volume":"19","author":"Maes","year":"2010","journal-title":"Dev Cell"},{"key":"10.1016\/j.bone.2013.06.016_bb0685","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1186\/1471-2164-11-229","article-title":"Age-related molecular genetic changes of murine bone marrow mesenchymal stem cells","volume":"11","author":"Wilson","year":"2010","journal-title":"BMC Genomics"},{"key":"10.1016\/j.bone.2013.06.016_bb0690","doi-asserted-by":"crossref","first-page":"3101","DOI":"10.1172\/JCI61209","article-title":"Intracellular VEGF regulates the balance between osteoblast and adipocyte differentiation","volume":"122","author":"Liu","year":"2012","journal-title":"J Clin Invest"},{"key":"10.1016\/j.bone.2013.06.016_bb0695","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1083\/jcb.114.6.1275","article-title":"Phospholipase C release of basic fibroblast growth factor from human bone marrow cultures as a biologically active complex with a phosphatidylinositol-anchored heparan sulfate proteoglycan","volume":"114","author":"Brunner","year":"1991","journal-title":"J Cell Biol"},{"key":"10.1016\/j.bone.2013.06.016_bb0700","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1210\/endo.140.1.6442","article-title":"Prostaglandins regulate the expression of fibroblast growth factor-2 in bone","volume":"140","author":"Sabbieti","year":"1999","journal-title":"Endocrinology"},{"key":"10.1016\/j.bone.2013.06.016_bb0705","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.bone.2010.05.021","article-title":"Disruption of the Fgf2 gene activates the adipogenic and suppresses the osteogenic program in mesenchymal marrow stromal stem cells","volume":"47","author":"Xiao","year":"2010","journal-title":"Bone"},{"key":"10.1016\/j.bone.2013.06.016_bb0710","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.tig.2004.08.007","article-title":"Evolution of the Fgf and Fgfr gene families","volume":"20","author":"Itoh","year":"2004","journal-title":"Trends Genet"},{"key":"10.1016\/j.bone.2013.06.016_bb0715","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.cmet.2007.05.010","article-title":"FGF21: a missing link in the biology of fasting","volume":"5","author":"Reitman","year":"2007","journal-title":"Cell Metab"},{"key":"10.1016\/j.bone.2013.06.016_bb0720","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1073\/pnas.1200797109","article-title":"Fibroblast growth factor 21 promotes bone loss by potentiating the effects of peroxisome proliferator-activated receptor \u03b3","volume":"109","author":"Wei","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.bone.2013.06.016_bb0725","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1111\/j.1365-2443.2004.00786.x","article-title":"The transactivating function of peroxisome proliferator-activated receptor \u03b3 is negatively regulated by SUMO conjugation in the amino-terminal domain","volume":"9","author":"Yamashita","year":"2004","journal-title":"Genes Cells"},{"key":"10.1016\/j.bone.2013.06.016_bb0730","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.cell.2011.11.062","article-title":"Fibroblast growth factor-21 regulates PPAR\u03b3 activity and the antidiabetic actions of thiazolidinediones","volume":"148","author":"Dutchak","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.bone.2013.06.016_bb0735","doi-asserted-by":"crossref","first-page":"12553","DOI":"10.1073\/pnas.1006962107","article-title":"Fibroblast growth factor 21 regulates energy metabolism by activating the AMPK-SIRT1-PGC-1alpha pathway","volume":"107","author":"Chau","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.bone.2013.06.016_bb0740","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1093\/ajcn\/83.1.146","article-title":"Relation of body composition, fat mass and serum lipids to osteoporotic fractures and bone mineral density in Chinese men and women","volume":"83","author":"Hsu","year":"2006","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.bone.2013.06.016_bb0745","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1007\/s10654-004-1706-8","article-title":"Atherogenic lipid profile and elevated lipoprotein (a) are associated with lower bone mineral density in early postmenopausal overweight women","volume":"19","author":"Orozco","year":"2004","journal-title":"Eur J Epidemiol"},{"key":"10.1016\/j.bone.2013.06.016_bb0750","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1007\/s00198-005-1977-2","article-title":"Association between bone mineral densities and serum lipid profiles of pre- and post-menopausal rural women in South Korea","volume":"16","author":"Cui","year":"2005","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.bone.2013.06.016_bb0755","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1093\/jn\/136.1.159","article-title":"Dietary saturated fat intake is inversely associated with bone density in humans: analysis of NHANES III","volume":"136","author":"Corwin","year":"2006","journal-title":"J Nutr"},{"key":"10.1016\/j.bone.2013.06.016_bb0760","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1007\/BF00298425","article-title":"Diet, bone mass, and osteocalcin: a cross-sectional study","volume":"57","author":"Micha\u00eblsson","year":"1995","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.bone.2013.06.016_bb0765","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1007\/BF02509379","article-title":"Dietary protein intake and bone mass in women","volume":"58","author":"Cooper","year":"1996","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.bone.2013.06.016_bb0770","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1359\/jbmr.090813","article-title":"Short term exposure to low-carbohydrate\/high fat diets induces low bone mineral density and reduces bone formation in rats","volume":"25","author":"Bielohuby","year":"2010","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.bone.2013.06.016_bb0775","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1359\/jbmr.1999.14.12.2067","article-title":"Atherogenic diet and minimally oxidized low density lipoprotein inhibit ostegenic and promote adipogenic differentiation of marrow stromal cells","volume":"14","author":"Parhami","year":"1999","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.bone.2013.06.016_bb0780","doi-asserted-by":"crossref","first-page":"e13704","DOI":"10.1371\/journal.pone.0013704","article-title":"Obesity reduces bone density associated with activation of PPAR\u03b3 and suppression of Wnt\/\u00df-catenin in rapidly growing male rats","volume":"5","author":"Chen","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.bone.2013.06.016_bb0785","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1096\/fj.11-197822","article-title":"Inhibition of fetal bone development through epigenetic downregulation of HoxA10 in obese rats fed high-fat diet","volume":"26","author":"Chen","year":"2012","journal-title":"FASEB"},{"key":"10.1016\/j.bone.2013.06.016_bb0790","first-page":"200","article-title":"Characterization of cocoa butter extracted from hybrid cultivars of Theobroma cacao L","volume":"50","author":"Badilla","year":"2000","journal-title":"Arch Latinoam Nutr"},{"key":"10.1016\/j.bone.2013.06.016_bb0795","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1007\/BF02545036","article-title":"Composition of corn oil","volume":"42","author":"Beadle","year":"1965","journal-title":"J Am Oil Chem Soc"},{"key":"10.1016\/j.bone.2013.06.016_bb0800","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.1002\/jcp.22578","article-title":"t10c12-CLA maintains higher bone mineral density during aging by modulating osteoclastogenesis and bone marrow adiposity","volume":"226","author":"Rahman","year":"2011","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.bone.2013.06.016_bb0805","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.jnutbio.2010.03.015","article-title":"Combination of conjugated linoleic acid with fish oil prevents age-associated bone marrow adiposity in C57Bl\/6J mice","volume":"22","author":"Halade","year":"2011","journal-title":"J Nutr Biochem"},{"key":"10.1016\/j.bone.2013.06.016_bb0810","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1007\/s00198-012-2138-z","article-title":"The omega-6 arachidonic fatty acid, but not the omega-3 fatty acids, inhibits osteoblastogenesis and induces adipogenesis of human mesenchymal stem cells: potential implication in osteoporosis","volume":"24","author":"Casado-Diaz","year":"2013","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.bone.2013.06.016_bb0815","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1194\/jlr.M300120-JLR200","article-title":"Trans10, cis12-conjugated linoleic acid prevents triacylglycerol accumulation in adipocytes by acting as a PPARgamma modulator","volume":"44","author":"Granlund","year":"2003","journal-title":"J Lipid Res"},{"key":"10.1016\/j.bone.2013.06.016_bb0820","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/j.jnutbio.2008.08.008","article-title":"Regulation of osteoblast and adipocyte differentiation from human mesenchymal stem cells by conjugated linoleic acid","volume":"20","author":"Platt","year":"2009","journal-title":"J Nutr Biochem"},{"key":"10.1016\/j.bone.2013.06.016_bb0825","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.jnutbio.2012.03.017","article-title":"trans-10,cis-12 Conjugated linoleic acid promotes bone formation by inhibiting adipogenesis by peroxisome proliferator-activated receptor-\u03b3-dependent mechanisms and by directly enhancing osteoblastogenesis from bone marrow mesenchymal stem cells","volume":"24","author":"Kim","year":"2013","journal-title":"J Nutr Biochem"},{"key":"10.1016\/j.bone.2013.06.016_bb0830","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/S0006-291X(03)01408-6","article-title":"Simvastatin induces osteoblastic differentiation and inhibits adipocytic differentiation in mouse bone marrow stromal cells","volume":"308","author":"Song","year":"2003","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.bone.2013.06.016_bb0835","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/S8756-3282(03)00239-4","article-title":"Lovastatin inhibits adipogenic and stimulates osteogenic differentiation by suppressing PPARgamma2 and increasing Cbfa1\/Runx2 expression in bone marrow mesenchymal cell cultures","volume":"33","author":"Li","year":"2003","journal-title":"Bone"},{"key":"10.1016\/j.bone.2013.06.016_bb0840","first-page":"43","article-title":"The effect of simvastatin on the differentiation of marrow stromal cells from aging rats","volume":"64","author":"Liu","year":"2009","journal-title":"Pharmazie"},{"key":"10.1016\/j.bone.2013.06.016_bb0845","doi-asserted-by":"crossref","first-page":"72","DOI":"10.2165\/00003495-198800363-00016","article-title":"Mechanism of action and biological profile of HMG CoA reductase inhibitors. A new therapeutic alternative","volume":"36","author":"Slater","year":"1988","journal-title":"Drugs"},{"key":"10.1016\/j.bone.2013.06.016_bb0850","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1432-1033.1977.tb11637.x","article-title":"Inhibition of cholesterol synthesis in vitro and in vivo by ML-236A and ML-236B, competitive inhibitors of 3-hydroxy-3-methylglutaryl-coenzyme A reductase","volume":"77","author":"Endo","year":"1977","journal-title":"Eur J Biochem"},{"key":"10.1016\/j.bone.2013.06.016_bb0855","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.prostaglandins.2007.04.001","article-title":"Activation of peroxisome proliferator-activated receptor-gamma (PPAR-gamma) by atorvastatin is mediated by 15-deoxy-delta-12,14-PGJ2","volume":"84","author":"Ye","year":"2007","journal-title":"Prostaglandins Other Lipid Mediat"},{"key":"10.1016\/j.bone.2013.06.016_bb0860","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1161\/01.RES.0000268411.49545.9c","article-title":"Statins activate peroxisome proliferator-activated receptor gamma through extracellular signal-regulated kinase 1\/2 and p38 mitogen-activated protein kinase-dependent cyclooxygenase-2 expression in macrophages","volume":"100","author":"Yano","year":"2007","journal-title":"Circ Res"},{"key":"10.1016\/j.bone.2013.06.016_bb0865","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1038\/sj.bjp.0707250","article-title":"Anti-adipogenic action of pitavastatin occurs through the coordinate regulation of PPARgamma and Pref-1 expression","volume":"151","author":"Nicholson","year":"2007","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.bone.2013.06.016_bb0870","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1507\/endocrj.K06-127","article-title":"Short-term effects of atorvastatin on bone turnover in male patients with hypercholesterolemia","volume":"54","author":"Majima","year":"2007","journal-title":"Endocr J"},{"key":"10.1016\/j.bone.2013.06.016_bb0875","doi-asserted-by":"crossref","first-page":"4671","DOI":"10.1210\/jc.2006-1909","article-title":"Effects of atorvastatin on bone in postmenopausal women with dyslipidemia: a double-blind, placebo-controlled, dose-ranging trial","volume":"92","author":"Bone","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.bone.2013.06.016_bb0880","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1097\/gme.0b013e3181d3e036","article-title":"Statins and bone health in post-menopausal women: a systematic review of randomized controlled trials","volume":"17","author":"Yue","year":"2010","journal-title":"Menopause"},{"key":"10.1016\/j.bone.2013.06.016_bb0885","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.metabol.2004.01.010","article-title":"Simvastatin increases bone mineral density in hypercholesterolemic postmenopausal women","volume":"53","author":"Lupattelli","year":"2004","journal-title":"Metabolism"},{"key":"10.1016\/j.bone.2013.06.016_bb0890","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1016\/S0140-6736(00)02408-9","article-title":"Oral statins and increased bone-mineral density in postmenopausal women","volume":"355","author":"Edwards","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.bone.2013.06.016_bb0895","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1016\/j.bone.2007.02.019","article-title":"Effects of statins on bone mineral density: a meta-analysis of clinical studies","volume":"40","author":"Uzzan","year":"2007","journal-title":"Bone"},{"key":"10.1016\/j.bone.2013.06.016_bb0900","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1126\/science.286.5446.1946","article-title":"Stimulation of bone formation in vitro and in rodents by statins","volume":"286","author":"Mundy","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.bone.2013.06.016_bb0905","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1161\/hq1001.097781","article-title":"Effects of statins on bone mineral density and bone histomorphometry in rodents","volume":"21","author":"Maritz","year":"2001","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.bone.2013.06.016_bb0910","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/j.bone.2009.12.023","article-title":"Effects of statins vs non-statin lipid-lowering therapy on bone formation and bone mineral density biomarkers in patients with hyperlipidaemia","volume":"46","author":"Chuengsamarn","year":"2010","journal-title":"Bone"},{"key":"10.1016\/j.bone.2013.06.016_bb0915","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.bone.2011.09.056","article-title":"Geranylgeranyl pyrophosphate stimulates PPAR\u03b3 expression and adipogenesis through the inhibition of osteoblast differentiation","volume":"50","author":"Weivoda","year":"2012","journal-title":"Bone"},{"key":"10.1016\/j.bone.2013.06.016_bb0920","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1002\/1097-4644(20001201)79:3<407::AID-JCB60>3.0.CO;2-8","article-title":"Hormonal changes affect the bone and bone marrow cells in a rat model","volume":"79","author":"Benayahu","year":"2000","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.bone.2013.06.016_bb0925","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1007\/s10522-009-9221-7","article-title":"Effect of estrogens on bone marrow adipogenesis and Sirt1 in aging C57BL\/6J mice","volume":"10","author":"Elbaz","year":"2009","journal-title":"Biogerontology"},{"key":"10.1016\/j.bone.2013.06.016_bb0930","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1007\/BF03347039","article-title":"The effects of native and synthetic estrogenic compounds as well as vitamin D less-calcemic analogs on adipocytes content in rat bone marrow","volume":"34","author":"Somjen","year":"2001","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.bone.2013.06.016_bb0935","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1210\/endo.143.6.8854","article-title":"Estrogen promotes early osteoblast differentiation and inhibits adipocyte differentiation in mouse bone marrow stromal cell lines that express estrogen receptor (ER) alpha or beta","volume":"143","author":"Okazaki","year":"2002","journal-title":"Endocrinology"},{"key":"10.1016\/j.bone.2013.06.016_bb0940","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.tips.2004.12.009","article-title":"The emerging therapeutic potential of sirtuin-interacting drugs: from cell death to lifespan extension","volume":"26","author":"Porcu","year":"2005","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.bone.2013.06.016_bb0945","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1038\/nature02583","article-title":"Sirt1 promotes fat mobilization in white adipocytes by repressing PPAR-gamma","volume":"429","author":"Picard","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.bone.2013.06.016_bb0950","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1359\/jbmr.060415","article-title":"Activation of Sirt1 decreases adipocyte formation during osteoblast differentiation of mesenchymal stem cells","volume":"21","author":"Backesj\u00f6","year":"2006","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.bone.2013.06.016_bb0955","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.1002\/jbmr.460","article-title":"Resveratrol promotes osteogenesis of human mesenchymal stem cells by upregulating RUNX2 gene expression via the SIRT1\/FOXO3A axis","volume":"26","author":"Tseng","year":"2011","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.bone.2013.06.016_bb0960","doi-asserted-by":"crossref","first-page":"1589-165","DOI":"10.5344\/ajev.1995.46.2.159","article-title":"A global survey of trans-resveratrol concentrations in commercial wines","volume":"46","author":"Goldberg","year":"1995","journal-title":"Am J Enol Vitic"},{"key":"10.1016\/j.bone.2013.06.016_bb0965","doi-asserted-by":"crossref","first-page":"19385","DOI":"10.1074\/jbc.M702452200","article-title":"Forkhead proteins are critical for bone morphogenetic protein-2 regulation and anti-tumor activity of resveratrol","volume":"282","author":"Su","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bone.2013.06.016_bb0970","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/nature01960","article-title":"Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan","volume":"425","author":"Howitz","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.bone.2013.06.016_bb0975","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1210\/en.2003-1014","article-title":"The phytoestrogen genistein enhances osteogenesis and represses adipogenic differentiation of human primary bone marrow stromal cells","volume":"145","author":"Heim","year":"2004","journal-title":"Endocrinology"},{"key":"10.1016\/j.bone.2013.06.016_bb0980","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1097\/MED.0b013e32833f4867","article-title":"Phytoestrogens and bone health","volume":"17","author":"Lagari","year":"2010","journal-title":"Curr Opin Endocrinol Diab Obes"},{"key":"10.1016\/j.bone.2013.06.016_bb0985","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1002\/jcb.240500411","article-title":"Glucocorticoids promote development of the osteoblast phenotype by selectively modulating expression of cell growth and differentiation associated genes","volume":"50","author":"Shalhoub","year":"1992","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.bone.2013.06.016_bb0990","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1007\/s00198-007-0394-0","article-title":"Glucocorticoid-induced osteoporosis: pathophysiology and therapy","volume":"18","author":"Canalis","year":"2007","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.bone.2013.06.016_bb0995","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.amjmed.2008.11.027","article-title":"Bone, fat, and body composition: evolving concepts in the pathogenesis of osteoporosis","volume":"122","author":"Rosen","year":"2009","journal-title":"Am J Med"},{"key":"10.1016\/j.bone.2013.06.016_bb1000","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1074\/jbc.M702687200","article-title":"Osteoblasts directly control lineage commitment of mesenchymal progenitor cells through Wnt signaling","volume":"283","author":"Zhou","year":"2008","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bone.2013.06.016_bb1005","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1242\/dev.027706","article-title":"Glucocorticoid-dependent Wnt signaling by mature osteoblasts is a key regulator of cranial skeletal development in mice","volume":"136","author":"Zhou","year":"2009","journal-title":"Development"},{"key":"10.1016\/j.bone.2013.06.016_bb1010","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.bbrc.2005.01.117","article-title":"Glucocorticoid suppresses the canonical Wnt signal in cultured human osteoblasts","volume":"329","author":"Ohnaka","year":"2005","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.bone.2013.06.016_bb1015","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S8756-3282(02)00687-7","article-title":"Effects of cortisol and bone morphogenetic protein-2 on stromal cell differentiation: correlation with CCAAT-enhancer binding protein expression","volume":"30","author":"Pereira","year":"2002","journal-title":"Bone"},{"key":"10.1016\/j.bone.2013.06.016_bb1020","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s00223-010-9378-8","article-title":"Cannabinoids and bone: friend or foe?","volume":"87","author":"Idris","year":"2010","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.bone.2013.06.016_bb1025","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1054\/plef.2001.0341","article-title":"Cannabinoid receptors and their ligands","volume":"66","author":"Pertwee","year":"2002","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"10.1016\/j.bone.2013.06.016_bb1030","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1038\/sj.bjp.0707460","article-title":"The orphan receptor GPR55 is a novel cannabinoid receptor","volume":"152","author":"Ryberg","year":"2007","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.bone.2013.06.016_bb1035","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1038\/nm1255","article-title":"Regulation of bone mass, bone loss and osteoclast activity by cannabinoid receptors","volume":"11","author":"Idris","year":"2005","journal-title":"Nat Med"},{"key":"10.1016\/j.bone.2013.06.016_bb1040","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1073\/pnas.0504187103","article-title":"Peripheral cannabinoid receptor, CB2, regulates bone mass","volume":"103","author":"Ofek","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.bone.2013.06.016_bb1045","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.cmet.2009.07.006","article-title":"Cannabinoid receptor type I protects against age-related osteoporosis by regulating osteoblast and adipocyte differentiation in marrow stromal cells","volume":"10","author":"Idris","year":"2009","journal-title":"Cell Metab"},{"key":"10.1016\/j.bone.2013.06.016_bb1050","doi-asserted-by":"crossref","first-page":"16511","DOI":"10.1073\/pnas.0902743106","article-title":"The putative cannabinoid receptor GPR55 affects osteoclast function in vitro and bone mass in vivo","volume":"106","author":"Whyte","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.bone.2013.06.016_bb1055","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1002\/art.33457","article-title":"Cannabinoid receptor 1 mediates glucocorticoid-induced bone loss in rats by perturbing bone mineral acquisition and marrow adipogenesis","volume":"64","author":"Ko","year":"2012","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.bone.2013.06.016_bb1060","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.ecl.2004.04.003","article-title":"Glitazones and the management of insulin resistance: what they do and how might they be used","volume":"33","author":"Einhorn","year":"2004","journal-title":"Endocrinol Metab Clin North Am"},{"key":"10.1016\/j.bone.2013.06.016_bb1065","doi-asserted-by":"crossref","first-page":"12953","DOI":"10.1074\/jbc.270.22.12953","article-title":"An antidiabetic thiazolidinedione is a high affintiy ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma)","volume":"270","author":"Lehmann","year":"1995","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bone.2013.06.016_bb1070","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1172\/JCI1235","article-title":"Troglitazone increases the number of small adipocytes without the change of white adipose tissue mass in obese Zucker rats","volume":"101","author":"Okuno","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1016\/j.bone.2013.06.016_bb1075","doi-asserted-by":"crossref","first-page":"115","DOI":"10.2165\/11587580-000000000-00000","article-title":"Thiazolidinediones and risk of heart failure in patients with or at high risk of type 2 diabetes mellitus: a meta-analysis and meta-regression analysis of placebo-controlled randomized clinical trials","volume":"11","author":"Hernandez","year":"2011","journal-title":"Am J Cardiovasc Drugs"},{"key":"10.1016\/j.bone.2013.06.016_bb1080","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1056\/NEJMp1010788","article-title":"Regulatory action on rosiglitazone by the U.S. Food and Drug Administration","volume":"363","author":"Woodcock","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bone.2013.06.016_bb1085","doi-asserted-by":"crossref","first-page":"c3862","DOI":"10.1136\/bmj.c3862","article-title":"FDA committee urges tight restriction on rosiglitazone","volume":"341","author":"Roehr","year":"2010","journal-title":"BMJ"},{"key":"10.1016\/j.bone.2013.06.016_bb1090","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1210\/jc.2007-2249","article-title":"Association of pioglitazone treatment with reduced bone mineral density in obese premenopausal patients with polycystic ovarian syndrome: a randomized placebo-controlled trial","volume":"93","author":"Glintborg","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.bone.2013.06.016_bb1095","doi-asserted-by":"crossref","first-page":"3349","DOI":"10.1210\/jc.2005-2226","article-title":"Thiazolidinedione use and bone loss in older diabetic adults","volume":"91","author":"Schwartz","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.bone.2013.06.016_bb1100","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1592\/phco.30.7.716","article-title":"Bone loss and fracture risk associated with thiazolidinedione therapy","volume":"30","author":"Riche","year":"2010","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.bone.2013.06.016_bb1105","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1210\/jc.2009-1385","article-title":"Thiazolidinedione use and the longitudinal risk of fractures in patients with type 2 diabetes mellitus","volume":"95","author":"Habib","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.bone.2013.06.016_bb1110","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1111\/j.1463-1326.2010.01225.x","article-title":"Rosiglitazone and pioglitazone increase fracture risk in women and men with type 2 diabetes","volume":"12","author":"Aubert","year":"2010","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.bone.2013.06.016_bb1115","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1210\/en.2003-0746","article-title":"Bone is a target for the antidiabetic compound rosiglitazone","volume":"145","author":"Rzonca","year":"2004","journal-title":"Endocrinology"},{"key":"10.1016\/j.bone.2013.06.016_bb1120","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1210\/en.2004-0735","article-title":"Rosiglitazone causes bone loss in mice by suppressing osteoblast differentiation and bone formation","volume":"146","author":"Ali","year":"2005","journal-title":"Endocrinology"},{"key":"10.1016\/j.bone.2013.06.016_bb1125","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1530\/EJE-11-1075","article-title":"Pioglitazone increases bone marrow fat in type 2 diabetes: results from a randomized controlled trial","volume":"166","author":"Grey","year":"2012","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.bone.2013.06.016_bb1130","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1210\/jc.2009-1947","article-title":"Long-term use of bisphosphonates in osteoporosis","volume":"95","author":"Watts","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.bone.2013.06.016_bb1135","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1359\/jbmr.070701","article-title":"Alendronate has an anabolic effect on bone through the differentiation of mesenchymal stem cells","volume":"22","author":"Duque","year":"2007","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.bone.2013.06.016_bb1140","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1007\/s00198-010-1353-8","article-title":"Effects of risedronate on bone marrow adipocytes in postmenopausal women","volume":"22","author":"Duque","year":"2011","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.bone.2013.06.016_bb1145","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.bone.2012.11.002","article-title":"Marrow adiposity recovery after early zoledronic acid treatment of glucocorticoid-induced bone loss in rabbits assessed by magnetic resonance spectroscopy","volume":"52","author":"Li","year":"2013","journal-title":"Bone"},{"key":"10.1016\/j.bone.2013.06.016_bb1150","doi-asserted-by":"crossref","first-page":"E21","DOI":"10.1016\/j.jss.2012.03.018","article-title":"Risedronate inhibits bone marrow mesenchymal stem cell adipogenesis and switches RANKL\/OPG ratio to impair osteoclast differentiation","volume":"180","author":"Jin","year":"2013","journal-title":"J Surg Res"},{"key":"10.1016\/j.bone.2013.06.016_bb1155","doi-asserted-by":"crossref","first-page":"e6189","DOI":"10.1371\/journal.pone.0006189","article-title":"Insulin stimulates adipogenesis through the Akt-TSC2-mTORC1 pathway","volume":"4","author":"Zhang","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.bone.2013.06.016_bb1160","doi-asserted-by":"crossref","first-page":"2748","DOI":"10.2337\/diabetes.53.11.2748","article-title":"Regulation of peroxisome proliferator-activated receptor-\u03b3 activity by mammalian target of rapamycin and amino acids in adipogenesis","volume":"53","author":"Kim","year":"2004","journal-title":"Diabetes"},{"key":"10.1016\/j.bone.2013.06.016_bb1165","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1056\/NEJMoa022436","article-title":"The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis","volume":"350","author":"Meunier","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bone.2013.06.016_bb1170","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1007\/s00198-010-1369-0","article-title":"How strontium ranelate, via opposite effects on bone resorption and formation, prevents osteoporosis","volume":"22","author":"Marie","year":"2011","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.bone.2013.06.016_bb1175","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.bone.2011.07.038","article-title":"Reduction by strontium of the bone marrow adiposity in mice and repression of the adipogenic commitment of multipotent C3H10T1\/2 cells","volume":"50","author":"Fournier","year":"2012","journal-title":"Bone"},{"key":"10.1016\/j.bone.2013.06.016_bb1180","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/j.1474-9726.2012.00804.x","article-title":"Strontium ranelate rebalances bone marrow adipogenesis and osteblastogenesis in senescent osteopenic mice through NFATc\/Maf and Wnt signaling","volume":"11","author":"Saidak","year":"2012","journal-title":"Aging Cell"},{"key":"10.1016\/j.bone.2013.06.016_bb1185","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1038\/nrrheum.2009.137","article-title":"Wnt and PPARgamma signaling in osteoblastogenesis and adipogenesis","volume":"5","author":"Takada","year":"2009","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.bone.2013.06.016_bb1190","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/S1534-5807(02)00360-X","article-title":"The retinoblastoma-histone deacetylase 3 complex inhibits PPARgamma and adipocyte differentiation","volume":"3","author":"Fajas","year":"2002","journal-title":"Dev Cell"},{"key":"10.1016\/j.bone.2013.06.016_bb1195","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.1210\/endo.143.6.8834","article-title":"Divergent effects of selective peroxisome proliferator-activated receptor-\u03b32 ligands on adipocyte versus osteoblast differentiation","volume":"143","author":"Lecka-Czernik","year":"2002","journal-title":"Endocrinology"},{"key":"10.1016\/j.bone.2013.06.016_bb1200","doi-asserted-by":"crossref","first-page":"936906","DOI":"10.1155\/2008\/936906","article-title":"The development of INT131 as a selective PPAR\u03b3 modulator: approach to a safer insulin sensitizer","volume":"2008","author":"Higgins","year":"2008","journal-title":"PPAR Res"},{"key":"10.1016\/j.bone.2013.06.016_bb1205","doi-asserted-by":"crossref","first-page":"267S","DOI":"10.3945\/ajcn.2009.28449E","article-title":"Selective peroxisome proliferator-activated receptor-\u03b3 modulation as a strategy for safer therapeutic PPAR\u03b3 activation","volume":"91","author":"Higgins","year":"2010","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.bone.2013.06.016_bb1210","doi-asserted-by":"crossref","first-page":"E552","DOI":"10.1152\/ajpendo.00569.2011","article-title":"Selective PPAR\u03b3 modulator INT131 normalizes insulin signaling defects and improves bone mass in diet-induced obese mice","volume":"302","author":"Lee","year":"2012","journal-title":"Am J Physiol Endocrinol Metab"}],"container-title":["Bone"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328213002342?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328213002342?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,7,2]],"date-time":"2023-07-02T14:42:49Z","timestamp":1688308969000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S8756328213002342"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10]]},"references-count":242,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["S8756328213002342"],"URL":"https:\/\/doi.org\/10.1016\/j.bone.2013.06.016","relation":{},"ISSN":["8756-3282"],"issn-type":[{"value":"8756-3282","type":"print"}],"subject":[],"published":{"date-parts":[[2013,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Determinants of bone marrow adiposity: The modulation of peroxisome proliferator-activated receptor-\u03b32 activity as a central mechanism","name":"articletitle","label":"Article Title"},{"value":"Bone","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bone.2013.06.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}